Austrian Registry on the Outcome of Monochorionic Pregnancies

NCT03171909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-05-31

No results posted yet for this study

Summary

About one third of twin pregnancies are resulting from a single fertilized oocyte. Two third of these monozygotic twins share a common placenta and are therefore called monochorionic. Due to placental sharing and the ever-present inter-fetal vascular connections, specific complications may arise and lead to an increased risk of intrauterine death and long-term neurodevelopmental impairment. Specific complications include twin-to-twin transfusion syndrome (TTTS), twin-anemia-polycythemia sequence (TAPS), selective intrauterine growth restriction (sIUGR) and discordant major anomalies, occurring in about 10%, 5%, 20% and 6% of monochorionic diamniotic twins. Prenatal interventions may improve perinatal and long-term outcome of affected fetuses. However, general knowledge about early diagnosis of monochorionic twins and their specific complications is still limited in a significant number of practitioners in Austria and systematic analysis of pregnancy outcomes are not conducted.

In this prospective multicenter registry study, the investigators aim to include all monochorionic pregnancies in Austria. Main outcome parameter is the occurrence of complications. Secondary outcomes are gestational age at occurrence of complications, gestational age delivery and neonatal outcome. The investigators also strive for long-term outcome, especially of infants following complicated pregnancies or preterm birth.

Conditions

  • Twin Dichorionic Diamniotic Placenta
  • Twin Monochorionic Monoamniotic Placenta
  • Twin-To-Twin Transfusion Syndrome
  • Twin Pregnancy With Antenatal Problem

Sponsors & Collaborators

  • Medical University of Vienna

    collaborator OTHER
  • Medical University Innsbruck

    collaborator OTHER
  • Johannes Kepler University of Linz

    collaborator OTHER
  • Paracelsus Medical University

    collaborator OTHER
  • Klinikum Klagenfurt am Wörthersee

    collaborator OTHER
  • Brothers of Saint John of God Eisenstadt

    collaborator UNKNOWN
  • SMZ-Ost Donauspital

    collaborator OTHER
  • Hospital Hochsteiermark

    collaborator UNKNOWN
  • Landesklinikum Sankt Polten

    collaborator OTHER
  • Klinikum Wels-Grieskirchen

    collaborator OTHER
  • Landeskrankenhaus Feldkirch

    collaborator OTHER
  • Landesklinkum Wiener Neustadt

    collaborator OTHER
  • Mödling Hospital

    collaborator OTHER
  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Philipp Klaritsch, MD · Department of Obstetrics and Gynecology, Medical University of Graz, Austria

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03171909 on ClinicalTrials.gov